Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +275.3% | +688.6% | 3 / 3 | +12.5% | +8.89 pp | +13.37 pp | +7.6% | 0.46 | 48.10 | 3.310 | +12,5% | 632 | +275,2% | 48.10 | 140.97 | −65,9% |
| Pts | 12 | 12 | 12 | 4 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 80.000 (close price on 2026-10-19)EPS (TTM): 1.663
Financial charts
1.Revenue & growth
VND bn3.310Q2/26
1.Revenue & growth
VND bn3.310Q2/26
2.Profit & growth
VND bn632Q2/26
3.Profit mix (Penman)
VND bn3.155Q2/26
4.Margins & cost structure
%37.4%Q2/26
5.Returns & cash cycle
% · days6.5%Q2/26
6.Earnings quality & cash
VND bn-5.826Q2/26
7.Asset structure
VND bn119.200Q2/26
8.Funding & debt health
VND bn · times119.200Q2/26
9.Revenue backlog
VND bn15.275Q2/26
10.Valuation
times · %48,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %337Q2/26
Adjusted EPS growth, latest quarter
258%
Average adjusted EPS growth, 3 quarters
914%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
4.7%
Source: vnstockData through Q2/26